POZEN Logo
Print Page   Close Window

Press Release

POZEN Announces April 27 Webcast of First Quarter 2006 Results

CHAPEL HILL, N.C.--(BUSINESS WIRE)--April 13, 2006--POZEN Inc. (NASDAQ: POZN), announced today that it will release first quarter 2006 results on April 27, 2006, before the market opens.

The announcement will be followed by a live webcast at 11:00 a.m. Eastern Time with a discussion by POZEN management of the earnings and business results. The webcast can be accessed on POZEN's website at www.pozen.com and will be archived and available for replay. The first quarter 2006 earnings release can be accessed in the News section of POZEN's website.

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of acute and chronic pain, migraine, and other pain-related conditions. POZEN has a development and commercialization alliance with GlaxoSmithKline. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

CONTACT: POZEN Inc.
Bill Hodges, Chief Financial Officer, 919-913-1030 or
Fran Barsky, Director, Investor Relations, 919-913-1044

SOURCE: POZEN Inc.